China, Sept. 23 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A National Multicenter RealWorld Study of Neoadjuvant Immunotherapy for EarlyStage TripleNegative Breast Cancer'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600133206
Registration Time: 2026/09/22
Type: Observational study
Primary Sponsor: The First Affiliated Hospital of Army Medical University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=344773
Published by HT Digital Content Services with permission from Health Daily Digest....